Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584–90.

Article  PubMed  Google Scholar 

Liu C, Shi J, Wang H, Yan X, Wang L, Ren J, et al. Population-level economic burden of Lung cancer in China: Provisional prevalence-based estimations, 2017–2030. Chin J Cancer Res. 2021;33(1):79–92.

Article  PubMed  PubMed Central  Google Scholar 

Kiadaliri A, Alava MH, Roos EM, Englund M, Mapping. EQ-5D-3L from the knee injury and osteoarthritis outcome score (KOOS). Qual Life Res. 2020;29(1):265–74.

Article  PubMed  Google Scholar 

NICE. (2013). Guide to the methods of technology appraisal 2013, National Institute for Health and Care Excellence, UK. https://www.nice.org.uk/process/pmg9/chapter/foreword.

Badia X, Trainer P, Biermasz NR, Tiemensma J, Carreño A, Roset M, et al. Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly. J Med Econ. 2018;21(4):382–89.

Article  PubMed  Google Scholar 

Brazier JE, Yang Y, Tsuchiya A, Rowen DL. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2):215–25.

Article  PubMed  Google Scholar 

Sturkenboom R, Keszthelyi D, Brandts L, Weerts ZZRM, Snijkers JTW, Masclee AAM, et al. The estimation of a preference-based single index for the IBS-QoL by mapping to the EQ-5D-5L in patients with irritable bowel syndrome. Qual Life Res. 2022;31(4):1209–21.

Article  PubMed  Google Scholar 

Wailoo AJ, Hernandez-Alava M, Manca A, Mejia A, Ray J, Crawford B, et al. Mapping to estimate health-state utility from non–preference-based outcome measures: an ISPOR good practices for outcomes research task force report. Value Health. 2017;20(1):18–27.

Article  PubMed  Google Scholar 

Mukuria C, Rowen D, Harnan S, Rawdin A, Wong R, Ara R, et al. An updated systematic review of studies mapping (or cross-walking) measures of health-related quality of life to generic preference-based measures to generate utility values. Appl Health Econ Health Policy. 2019;17(3):295–313.

Article  PubMed  Google Scholar 

Nahvijou A, Safari H, Yousefi M, Rajabi M, Arab-Zozani M, Ameri H. Mapping the cancer-specific FACT-B onto the generic SF-6Dv2. Breast Cancer. 2021;28(1):130–6.

Article  PubMed  Google Scholar 

Yousefi M, Nahvijou A, Sari AA, Ameri H. Mapping QLQ-C30 onto EQ-5D-5L and SF-6D-V2 in patients with colorectal and Breast Cancer from a developing country. Value Health Reg Issues. 2021;24:57–66.

Article  PubMed  Google Scholar 

Hernández Alava M, Wailoo A, Wolfe F, Michaud K. A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes. Med Decis Making. 2014;34(7):919–30.

Article  PubMed  Google Scholar 

Kent S, Gray A, Schlackow I, Jenkinson C, McIntosh E. Mapping from the Parkinson’s Disease questionnaire PDQ-39 to the generic EuroQol EQ-5D-3L: the value of mixture models. Med Decis Making. 2015;35(7):902–11.

Article  PubMed  Google Scholar 

Ara R, Rowen D, Mukuria C. The use of mapping to estimate health state utility values. PharmacoEconomics. 2017;35(Suppl 1):57–66.

Article  PubMed  Google Scholar 

Gray L, A AMH. A command for fitting mixture regression models for bounded dependent variables using the beta distribution. The Stata J. 2018;18(1):51–75.

Article  Google Scholar 

Kontodimopoulos N. The potential for a generally applicable mapping model between QLQ-C30 and SF-6D in patients with different cancers: a comparison of regression-based methods. Qual Life Res. 2015;24(6):1535–44.

Article  PubMed  Google Scholar 

Teckle P, McTaggart-Cowan H, Van der Hoek K, Chia S, Melosky B, Gelmon K, et al. Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D. Health Qual Life Outcomes. 2013;11:203.

Article  PubMed  PubMed Central  Google Scholar 

Yang Q, Huang D, Jiang L, Tang Y, Zeng D, Obtaining. SF-6D utilities from FACT-H&N in thyroid carcinoma patients: development and results from a mapping study. Front Endocrinol (Lausanne). 2023;14:1160882.

Article  PubMed  Google Scholar 

Dakin H, Abel L, Burns R, Yang Y. Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement. Health Qual Life Outcomes. 2018;16(1):31.

Article  PubMed  PubMed Central  Google Scholar 

Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, et al. The MAPS reporting statement for studies mapping onto generic preference-based outcome measures: explanation and elaboration. PharmacoEconomics. 2015;33(10):993–1011.

Article  PubMed  Google Scholar 

Longworth L, Yang Y, Young T, Mulhern B, Hernández Alava M, Mukuria C, et al. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess. 2014;18(9):1–224.

Article  PubMed  PubMed Central  Google Scholar 

Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer. 1995;12(3):199–220.

Article  CAS  PubMed  Google Scholar 

Wan C, Zhang C, Cai L, Tu X, Feng C, Luo J, et al. Psychometric properties of the Chinese version of the FACT-L for measuring quality of life in patients with Lung cancer. Lung Cancer. 2007;56(3):415–21.

Article  PubMed  Google Scholar 

Brazier J, Usherwood T, Harper R, Thomas K. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol. 1998;51(11):1115–28.

Article  CAS  PubMed  Google Scholar 

Ameri H, Safari H, Poder T. Exploring the consistency of the SF-6Dv2 in a Breast cancer population. Expert Rev Pharmacoecon Outcomes Res. 2021;21(5):1017–24.

Article  PubMed  Google Scholar 

McGhee SM, Brazier J, Lam CL, Wong LC, Chau J, Cheung A, et al. Quality-adjusted life years: population-specific measurement of the quality component. Hong Kong Med J. 2011;17(6):17–21.

PubMed  Google Scholar 

Vilsbøll AW, Kragh N, Hahn-Pedersen J, Jensen CE. Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study. Qual Life Res. 2020;29(9):2529–39.

Article  PubMed  PubMed Central  Google Scholar 

Lamu AN, Chen G, Gamst-Klaussen T, Olsen JA. Do country-specific preference weights matter in the choice of mapping algorithms? The case of mapping the Diabetes-39 onto eight country-specific EQ-5D-5L value sets. Qual Life Res. 2018;27(7):1801–14.

Article  PubMed  Google Scholar 

Oppe M, Devlin N, Black N. Comparison of the underlying constructs of the EQ-5D and Oxford Hip score: implications for mapping. Value Health. 2011;14(6):884–91.

Article  PubMed  Google Scholar 

Hernández Alava M, Wailoo AJ, Ara R. Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values. Value Health. 2012;15(3):550–61.

Article  PubMed  Google Scholar 

Pereira GHA, Botter DA, Sandoval MC. The truncated inflated beta distribution. Commun Statistics-Theory Method. 2012;41(5):907–19.

Article  Google Scholar 

Lamont AE, Vermunt JK, Van Horn ML. Regression mixture models: does modeling the covariance between Independent variables and latent classes improve the results? Multivar Behav Res. 2016;51(1):35–52.

Article  Google Scholar 

Gray LA, Hernández Alava M, Wailoo AJ. Development of methods for the mapping of utilities using mixture models: mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in patients with Asthma. Value Health. 2018;21(6):748–57.

Article  PubMed  PubMed Central  Google Scholar 

Barnhart HX, Haber M, Song J. Overall concordance correlation coefficient for evaluating agreement among multiple observers. Biometrics. 2002;58(4):1020–7.

Article  PubMed  Google Scholar 

Gray LA, Hernandez Alava M, Wailoo AJ. Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with Breast cancer. BMC Cancer. 2021;21(1):1237.

Article  PubMed  PubMed Central  Google Scholar 

Ameri H, Yousefi M, Yaseri M, Nahvijou A, Arab M, Akbari Sari A. Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in Colorectal cancer patients. Expert Rev Pharmacoecon Outcomes Res. 2019;19(1):89–96.

Article  PubMed  Google Scholar 

Lim J, Choi SE, Bae E, Kang D, Lim EA, Shin GS. Mapping analysis to estimate EQ-5D utility values using the COPD assessment test in Korea. Health Qual Life Outcomes. 2019;17(1):97.

Article  PubMed  PubMed Central  Google Scholar 

Gray LA, Wailoo AJ, Hernandez Alava M. Mapping the FACT-B instrument to EQ-5D-3L in patients with Breast cancer using adjusted limited dependent variable mixture models versus response mapping. Value Health. 2018;21(12):1399–405.

Article  PubMed  PubMed Central  Google Scholar 

Hagiwara Y, Shiroiwa T, Taira N, Kawahara T, Konomura K, Noto S, et al. Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer. Health Qual Life Outcomes. 2020;18(1):354.